Lisocabtagene Maraleucel (Liso-Cel) in Patients (pt) with R/R CLL/SLL: 24-Mo Median Follow-up of TRANSCEND CLL 004

Nirav N. Shah,Tanya Siddiqi,David G. Maloney,Saad S. Kenderian, Danielle M. Brander,Kathleen A. Dorritie,Jacob D. Soumerai,Peter A. Riedell, Rajneesh Nath,Bita Fakhri,Deborah M. Stephens,Shuo Ma,Tatyana Feldman, Scott R. Solomon,Stephen J. Schuster,Serena Perna,Sherilyn A. Tuazon,San-San Ou, Neha Rane,William G. Wierda

Transplantation and cellular therapy（2024）

引用 0|浏览4

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要